Targeting glycolysis: A fragment based approach towards bifunctional inhibitors of hLDH-5
hLDH-5 has emerged as a promising target for anti-glycolytic cancer chemotherapy. Here we report a first generation of bifunctional inhibitors, which show promising activity against hLDH-5.
Moorhouse, Adam D.,Spiteri, Christian,Sharma, Pallavi,Zloh, Mire,Moses, John E.
p. 230 - 232
(2011/03/22)
More Articles about upstream products of 1262304-23-3
Get Best Price for1262304-23-34-(4-(4-(3-(3-(4-(1H-indol-3-yl)-2,5-dioxo-2,5-dihydro-1H-pyrrol-3-yl)-indol-1-yl)-propyl)-(1,2,3)triazol-1-yl)-phenyl)-butyric acid